Skip to content

CP4ACS - Delphi Study to Determine Appropriateness of STEMI Quality Indicators in Belgium

Quality of Care for STEMI - Patients. a Research to Determine Appropriateness of STEMI Quality Indicators in Belgium, a RAND/UCLA Modified Delphi Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02030210
Enrollment
32
Registered
2014-01-08
Start date
2013-07-31
Completion date
2013-11-30
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality Indicators, STEMI

Keywords

Quality improvement, STEMI, Belgium

Brief summary

RAND/UCLA modified Delphi study on quality indicators for STEMI to determine the appropriateness of quality indicators retrieved from literature and guideline review. We aim to engage 20 cardiologists and 20 nurses with relevant experience in the care for STEMI patients.

Interventions

None listed

Sponsors

Universitaire Ziekenhuizen KU Leuven
CollaboratorOTHER
KU Leuven
CollaboratorOTHER
European Pathway Association
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* cardiologist or cardio nurse with relevant experience in the care for STEMI patients

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
validated quality indicators for STEMI care in belgium (both on patient and on hospital level)2 months33 experts in cardioloy, cardio nursing and quality rated quality indicators for STEMI care in belgian hospitals on a 9 point Likert Scale. All indicators with a median score between 7 and 9 were discussed in an expert panel. The expert panel selected validated quality inidicators for STEMI care.

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026